Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $878.26 | 65 | 98.7% |
| Education | $11.69 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $71.99 | 7 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $71.95 | 6 | $0 (2019) |
| PFIZER INC. | $69.66 | 6 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $59.52 | 5 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $41.65 | 3 | $0 (2023) |
| Daiichi Sankyo Inc. | $37.12 | 2 | $0 (2023) |
| Lundbeck LLC | $37.06 | 2 | $0 (2023) |
| Melinta Therapeutics, Inc. | $34.74 | 3 | $0 (2019) |
| Philips Electronics North America Corporation | $33.69 | 3 | $0 (2020) |
| ABBVIE INC. | $28.06 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.98 | 4 | Radius Health, Inc. ($21.71) |
| 2023 | $121.78 | 7 | Amgen Inc. ($21.88) |
| 2022 | $128.63 | 8 | Abbott Laboratories ($23.07) |
| 2021 | $161.75 | 11 | Eisai Inc. ($19.34) |
| 2020 | $23.67 | 2 | AstraZeneca Pharmaceuticals LP ($12.66) |
| 2019 | $109.14 | 9 | Melinta Therapeutics, Inc. ($23.02) |
| 2018 | $170.36 | 16 | Takeda Pharmaceuticals U.S.A., Inc. ($27.86) |
| 2017 | $101.64 | 9 | Ironwood Pharmaceuticals, Inc ($36.64) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: HFCWO | ||||||
| 10/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Rare Disease | ||||||
| 08/15/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $21.71 | General |
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Inflammation | ||||||
| 08/30/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: NEUROLOGY | ||||||
| 08/15/2023 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 03/02/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: CNS | ||||||
| 01/30/2023 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $13.84 | General |
| 11/16/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/20/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Diabetes Care | ||||||
| 05/19/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.71 | General |
| Category: NEUROLOGY | ||||||
| 04/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: DIABETES | ||||||
| 02/05/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: VACCINES | ||||||
| 01/26/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Urology | ||||||
| 12/14/2021 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| 11/29/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Central Nervous System | ||||||
| 11/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2021 | TherapeuticsMD, Inc. | ANNOVERA (Drug), IMVEXXY | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 11/03/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Cardio-renal | ||||||
| 10/11/2021 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,942 | 2,561 | $404,515 | $95,394 |
| 2022 | 27 | 2,227 | 3,029 | $466,405 | $110,487 |
| 2021 | 29 | 2,059 | 2,831 | $401,616 | $104,066 |
| 2020 | 24 | 1,958 | 2,677 | $367,309 | $84,791 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 256 | 432 | $157,140 | $35,072 | 22.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 166 | 166 | $67,393 | $21,401 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 50 | $25,657 | $6,180 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 109 | $28,124 | $6,148 | 21.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 202 | 267 | $26,625 | $3,490 | 13.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 249 | 408 | $11,244 | $3,427 | 30.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 18 | $10,546 | $2,935 | 27.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 29 | 53 | $9,511 | $2,397 | 25.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 192 | 281 | $17,692 | $2,329 | 13.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $7,272 | $2,298 | 31.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 31 | $2,292 | $2,223 | 97.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 123 | 174 | $8,799 | $1,647 | 18.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 79 | 79 | $8,604 | $1,495 | 17.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 35 | $1,477 | $1,047 | 70.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 78 | 82 | $6,448 | $848.70 | 13.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 42 | 49 | $4,768 | $806.54 | 16.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 65 | 76 | $4,163 | $481.84 | 11.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 64 | 65 | $1,741 | $330.20 | 19.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 47 | 47 | $1,417 | $266.02 | 18.8% |
| 84156 | Total protein level, urine | Office | 2023 | 63 | 64 | $1,389 | $226.80 | 16.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 16 | $712.32 | $137.52 | 19.3% |
| 87088 | Bacterial urine culture | Office | 2023 | 13 | 14 | $671.44 | $111.02 | 16.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 26 | 31 | $830.80 | $96.41 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 277 | 507 | $179,194 | $40,223 | 22.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 195 | 195 | $78,419 | $25,692 | 32.8% |
About Dr. Michael Fraley, MD
Dr. Michael Fraley, MD is a Family Medicine healthcare provider based in Mankato, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730168741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Fraley, MD has received a total of $889.95 in payments from pharmaceutical and medical device companies, with $72.98 received in 2024. These payments were reported across 66 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($878.26).
As a Medicare-enrolled provider, Fraley has provided services to 8,186 Medicare beneficiaries, totaling 11,098 services with total Medicare billing of $394,737. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mankato, MN
- Active Since 01/10/2006
- Last Updated 07/10/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730168741
Products in Payments
- JARDIANCE (Drug) $48.04
- INJECTAFER (Drug) $37.12
- VYEPTI (Biological) $37.06
- Orbactiv (Drug) $34.74
- LINZESS (Drug) $34.55
- VIAGRA (Drug) $32.17
- TRINTELLIX (Drug) $28.35
- VRAYLAR (Drug) $28.06
- XARELTO (Drug) $27.46
- AHPV (Device) $26.57
- Hetlioz (Drug) $24.54
- FREESTYLE LIBRE 2 (Device) $23.07
- Trintellix (Drug) $22.79
- Otezla (Drug) $21.88
- CHANTIX (Drug) $21.25
- Vivitrol (Drug) $21.00
- STRENSIQ (Biological) $17.82
- Vascepa (Drug) $17.10
- SMARTVEST (Device) $16.67
- PREVNAR 20 (Biological) $16.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mankato
John Benson, Md, MD
Family Medicine — Payments: $1,476
Richard Peller, Md, MD
Family Medicine — Payments: $1,220
Dr. Colin Weerts, D.o, D.O
Family Medicine — Payments: $1,158
Katie Thompson, D.o, D.O
Family Medicine — Payments: $1,110
Mitchell Heun, Md, MD
Family Medicine — Payments: $893.82
Bryan Pucik, Md, MD
Family Medicine — Payments: $788.89